Pediatric & Neonatal Dosage Handbook with International Trade Names Index: A Comprehensive Resource for All Clinicians Treating Pediatric and Neonatal Patients

(9)
Pediatric & Neonatal Dosage Handbook with International Trade Names Index: A Comprehensive Resource for All Clinicians Treating Pediatric and Neonatal Patients image
ISBN-10:

1591953146

ISBN-13:

9781591953142

Edition: 19
Released: Jan 01, 1605
Publisher: Lexi-Comp Inc
Format: Paperback, 2222 pages
Related ISBN: 9781591953135

Description:

hard to find

Best prices to buy, sell, or rent ISBN 9781591953142




Frequently Asked Questions about Pediatric & Neonatal Dosage Handbook with International Trade Names Index: A Comprehensive Resource for All Clinicians Treating Pediatric and Neonatal Patients

You can buy the Pediatric & Neonatal Dosage Handbook with International Trade Names Index: A Comprehensive Resource for All Clinicians Treating Pediatric and Neonatal Patients book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

If you’re interested in selling back the Pediatric & Neonatal Dosage Handbook with International Trade Names Index: A Comprehensive Resource for All Clinicians Treating Pediatric and Neonatal Patients book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Pediatric & Neonatal Dosage Handbook with International Trade Names Index: A Comprehensive Resource for All Clinicians Treating Pediatric and Neonatal Patients book, the best buyback offer comes from and is $ for the book in good condition.

The Pediatric & Neonatal Dosage Handbook with International Trade Names Index: A Comprehensive Resource for All Clinicians Treating Pediatric and Neonatal Patients book is in very low demand now as the rank for the book is 8,730,477 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.